191 related articles for article (PubMed ID: 31045757)
1. Efficacy of TCM therapy of tonifying lung-kidney's Qi-deficiency in a case of idiopathic pulmonary fibrosis: A case report.
Chen MJ; Yang GL; Ding YX; Tong ZQ
Medicine (Baltimore); 2019 May; 98(18):e15140. PubMed ID: 31045757
[TBL] [Abstract][Full Text] [Related]
2. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of an exploratory trial.
Yu XQ; Yang SG; Xie Y; Li JS
J Integr Med; 2020 Mar; 18(2):163-168. PubMed ID: 31928920
[TBL] [Abstract][Full Text] [Related]
3. Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis.
Bodlet A; Maury G; Jamart J; Dahlqvist C
Respir Med; 2013 Nov; 107(11):1781-8. PubMed ID: 24051272
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.
Callahan SJ; Xia M; Murray S; Flaherty KR
Respir Med; 2016 Oct; 119():96-101. PubMed ID: 27692155
[TBL] [Abstract][Full Text] [Related]
5. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
Feng H; Zhao Y; Li Z; Kang J
Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
[TBL] [Abstract][Full Text] [Related]
6. Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment.
Nathan SD; Costabel U; Albera C; Behr J; Wuyts WA; Kirchgaessler KU; Stauffer JL; Morgenthien E; Chou W; Limb SL; Noble PW
Respir Med; 2019 Jul; 153():44-51. PubMed ID: 31153107
[TBL] [Abstract][Full Text] [Related]
7. Modified Maimendong decoction in the treatment of patients with idiopathic pulmonary fibrosis: Study protocol for a randomized controlled trial.
Gan W; Huang Q; Xiao G; Luo Y; Wang J; Zhang C; Liang Y; Huang N; Liao T
Medicine (Baltimore); 2020 Dec; 99(49):e23460. PubMed ID: 33285745
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
Sun T; Liu J; Zhao W
Medicine (Baltimore); 2016 May; 95(19):e3629. PubMed ID: 27175674
[TBL] [Abstract][Full Text] [Related]
10. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
[TBL] [Abstract][Full Text] [Related]
11. Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial.
Behr J; Demedts M; Buhl R; Costabel U; Dekhuijzen RP; Jansen HM; MacNee W; Thomeer M; Wallaert B; Laurent F; Nicholson AG; Verbeken EK; Verschakelen J; Flower CD; Petruzzelli S; De Vuyst P; van den Bosch JM; Rodriguez-Becerra E; Lankhorst I; Sardina M; Boissard G;
Respir Res; 2009 Oct; 10(1):101. PubMed ID: 19860915
[TBL] [Abstract][Full Text] [Related]
12. Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
Raghu G; van den Blink B; Hamblin MJ; Brown AW; Golden JA; Ho LA; Wijsenbeek MS; Vasakova M; Pesci A; Antin-Ozerkis DE; Meyer KC; Kreuter M; Santin-Janin H; Mulder GJ; Bartholmai B; Gupta R; Richeldi L
JAMA; 2018 Jun; 319(22):2299-2307. PubMed ID: 29800034
[TBL] [Abstract][Full Text] [Related]
13. Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment.
Kondoh Y; Taniguchi H; Ogura T; Johkoh T; Fujimoto K; Sumikawa H; Kataoka K; Baba T; Colby TV; Kitaichi M
Respirology; 2013 Jul; 18(5):820-6. PubMed ID: 23489318
[TBL] [Abstract][Full Text] [Related]
14. Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.
Behr J; Kreuter M; Hoeper MM; Wirtz H; Klotsche J; Koschel D; Andreas S; Claussen M; Grohé C; Wilkens H; Randerath W; Skowasch D; Meyer FJ; Kirschner J; Gläser S; Herth FJ; Welte T; Huber RM; Neurohr C; Schwaiblmair M; Kohlhäufl M; Höffken G; Held M; Koch A; Bahmer T; Pittrow D
Eur Respir J; 2015 Jul; 46(1):186-96. PubMed ID: 25837040
[TBL] [Abstract][Full Text] [Related]
15. Independent Clinical Factors Relevant to Prognosis of Patients with Idiopathic Pulmonary Fibrosis.
Song H; Sun D; Ban C; Liu Y; Zhu M; Ye Q; Yan W; Ren Y; Dai H
Med Sci Monit; 2019 Jun; 25():4193-4201. PubMed ID: 31166938
[TBL] [Abstract][Full Text] [Related]
16. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M
Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509
[TBL] [Abstract][Full Text] [Related]
17. Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.
Jo HE; Glaspole I; Moodley Y; Chapman S; Ellis S; Goh N; Hopkins P; Keir G; Mahar A; Cooper W; Reynolds P; Haydn Walters E; Zappala C; Grainge C; Allan H; Macansh S; Corte TJ
BMC Pulm Med; 2018 Jan; 18(1):19. PubMed ID: 29370786
[TBL] [Abstract][Full Text] [Related]
18. Correlation of pulmonary function and usual interstitial pneumonia computed tomography patterns in idiopathic pulmonary fibrosis.
Arcadu A; Byrne SC; Pirina P; Hartman TE; Bartholmai BJ; Moua T
Respir Med; 2017 Aug; 129():152-157. PubMed ID: 28732823
[TBL] [Abstract][Full Text] [Related]
19. Clinical Impact of Emphysema Evaluated by High-Resolution Computed Tomography on Idiopathic Pulmonary Fibrosis Diagnosed by Surgical Lung Biopsy.
Kohashi Y; Arai T; Sugimoto C; Tachibana K; Akira M; Kitaichi M; Hayashi S; Inoue Y
Respiration; 2016; 92(4):220-228. PubMed ID: 27576553
[TBL] [Abstract][Full Text] [Related]
20. Safety and Tolerability of Alveolar Type II Cell Transplantation in Idiopathic Pulmonary Fibrosis.
Serrano-Mollar A; Gay-Jordi G; Guillamat-Prats R; Closa D; Hernandez-Gonzalez F; Marin P; Burgos F; Martorell J; Sánchez M; Arguis P; Soy D; Bayas JM; Ramirez J; Tetley TD; Molins L; de la Bellacasa JP; Rodríguez-Villar C; Rovira I; Fiblà JJ; Xaubet A;
Chest; 2016 Sep; 150(3):533-43. PubMed ID: 27020420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
